These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3352480)

  • 21. The influence of pH on urinary ionized [Ca2+]: differences between urinary tract stone formers and normal subjects.
    Langley SE; Fry CH
    Br J Urol; 1997 Jan; 79(1):8-14. PubMed ID: 9043487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton magnetic resonance in experimental acute and chronic renal failure in rats.
    Abrashkin S; Weininger J; Griffel L; Schneider R; Iaina A
    Ren Fail; 1987; 10(1):21-7. PubMed ID: 3823504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal proton magnetic resonance and bound and free water distribution in the normal, angiotensin II-and ADH-infused rats, before and after Gd DTPA paramagnetic enhancement.
    Iaina A; Abrashkin S; Weininger J; Azoury R
    Child Nephrol Urol; 1988-1989; 9(1-2):6-10. PubMed ID: 3251623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. URINARY EXCRETION OF CALCIUM AND CITRATE IN NORMAL INDIVIDUALS AND STONE FORMERS WITH VARIATION IN CALCIUM INTAKE.
    MCINTOSH HW; SERAGLIA M
    Can Med Assoc J; 1963 Dec; 89(24):1242-3. PubMed ID: 14084708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-dimensional electrophoretic analyses of urinary proteins in Chinese male urinary stone patients.
    Chen WC; Lee YH; Chao D; Huang JK
    Kaohsiung J Med Sci; 1997 May; 13(5):308-14. PubMed ID: 9226972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance relaxation times of percutaneously obtained normal and abnormal body fluids.
    Brown JJ; vanSonnenberg E; Gerber KH; Strich G; Wittich GR; Slutsky RA
    Radiology; 1985 Mar; 154(3):727-31. PubMed ID: 3969478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability of the calcium ion activity with pH in stone-forming and non-stone-forming urine.
    Thode J; Holgersen RB; Gerstenberg T
    Scand J Clin Lab Invest Suppl; 1993; 214():121-6. PubMed ID: 8332846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary pyrophosphate in patients with recurrent calcium urolithiasis and in healthy controls: a re-evaluation.
    Schwille PO; Rümenapf G; Wölfel G; Köhler R
    J Urol; 1988 Aug; 140(2):239-45. PubMed ID: 2840520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of excipients on the molecular mobility of lyophilized formulations, as measured by glass transition temperature and NMR relaxation-based critical mobility temperature.
    Yoshioka S; Aso Y; Kojima S
    Pharm Res; 1999 Jan; 16(1):135-40. PubMed ID: 9950292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary metabolic evaluation of stone formers-a Malaysian perspective.
    Hong YH; Dublin N; Razack AH; Mohd MA; Husain R
    Urology; 2012 Sep; 80(3):529-34. PubMed ID: 22578827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation.
    Drach GW; Thorson S; Randolph A
    J Urol; 1980 Apr; 123(4):519-23. PubMed ID: 7365890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Softening temperature of lyophilized bovine serum albumin and gamma-globulin as measured by spin-spin relaxation time of protein protons.
    Yoshioka S; Aso Y; Kojima S
    J Pharm Sci; 1997 Apr; 86(4):470-4. PubMed ID: 9109051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of spontaneous crystalluria in patients with calcium oxalate calculi].
    Nguyen HV; Daudon M; Réveillaud RJ; Jungers P
    Nephrologie; 1987; 8(2):65-9. PubMed ID: 3614507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the free Ca2+ in undiluted urine from stone formers and normal subjects using a new generation of ion-selective electrodes.
    Langley SE; Fry CH
    Br J Urol; 1995 Mar; 75(3):288-95. PubMed ID: 7735795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium oxalate crystallization properties in urine with different specific electrical conductivities.
    Tiselius HG
    J Urol; 1992 Sep; 148(3 Pt 2):990-4. PubMed ID: 1507357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evaluation of risk factors in male stone-formers attending a general hospital out-patient clinic.
    Ryall RL; Darroch JN; Marshall VR
    Br J Urol; 1984 Apr; 56(2):116-21. PubMed ID: 6498429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.